Predisposición adquirida al daño renal asociada al consumo de tabaco

  1. DE JUAN, Mario 1
  2. PRIETO, Marta
  3. HERNANDEZ, María Teresa
  4. SANZ, Francisco J.
  5. CASANOVA, Alfredo G.
  6. VICENTE, Laura
  7. PESCADOR, Moisés
  8. MORALES, Ana I.
  1. 1 Unidad de Toxicología del Departamento de Fisiología y Farmacología de la Universidad de Salamanca. Edificio Departamental, Lab. 223. Campus Miguel de Unamuno
Revue:
Farmajournal

ISSN: 2445-1355

Année de publication: 2020

Volumen: 5

Número: 1

Pages: 7-15

Type: Article

DOI: 10.14201/FJ202051715 DIALNET GOOGLE SCHOLAR lock_openAccès ouvert editor

D'autres publications dans: Farmajournal

Résumé

A relation between tobacco and renal damage has been described during the last years. Referring to early diagnosis of renal disease, our group has developed the acquired predisposition concept, which can be applied to the smoking patient context. So, our hypothesis is that tobacco may cause predisposition to acute kidney injury (AKI), which means smokers may suffer AKI after being exposed to any nephrotoxin, including under-toxicity-level doses. Our aim was to study the relationship between the predisposition biomarkers 1 (BM1), 2 (BM2) and 3 (BM3) (characterized in our laboratory) and tobacco consumption.Urinary samples were taken from smokers and non-smokers volunteers with no renal damage nor exposure to risk factors of renal disease. The plasma creatinine of the patients was obtained from their medical history. The cotinine levels, which inform of the grade of smoking, were measured by ELISA. The urinary creatinine, used to correct urinary concentrations of biomarkers, was measured with a commercial kit based on Jaffé reaction, and the urinary biomarkers levels were measured by Western blot.Only BM3 showed greater excretion in smoking patients than in non-smokers. However, that excretion is not related to cotinine levels. In any case, BM3 could be a good clinical biomarker of AKI predisposition which would help to prevent renal damage in smokers.

Références bibliographiques

  • Bonventre JV, Vaidya VS, Schmouder R, Feig P, Dieterle F. Next-generation biomarkers for detecting kidney toxicity. Nat Biotechnol. 2010; 28(5):436-440.
  • Christiansen JS. Cigarette smoking and prevalence of microangiopathy in juvenile-onset insulin-dependent diabetes mellitus. Diabetes. 1978; 1(3):146-149.
  • Esteller Pérez A, Cordero Sánchez M. Fundamentos de Fisiopatología. 1.ª ed. Madrid: MacGraw-Hill Interamericana; 1998.
  • FDA | Cigarettes [Internet]. fda.gov. [citado 4 de enero de 2018; actualizado 16 de agosto de 2019]. Disponible en: https://www.fda.gov/TobaccoProducts/Labeling/ProductsIngredientsComponents/ucm482563.htm.
  • FDA | Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke: Established List [Internet]. fda.gov. [citado 4 de enero de 2018; actualizado 7 de octubre de 2019]. Disponible en: https://www.fda.gov/TobaccoProducts/Labeling/RulesRegulationsGuidance/ucm297786.htm.
  • MedlinePlus enciclopedia médica | Examen de creatinina en la sangre [Internet]. medlineplus.gov. [citado 20 de junio de 2018; actualizado 2 de octubre de 2019]. Disponible en: https://medlineplus.gov/spanish/ency/article/003475.htm.
  • OMS | Tabaco [Internet]. WHO.int. [citado 22 de septiembre de 2017; actualizado 26 de julio de 2019]. Disponible en: http://www.who.int/mediacentre/factsheets/fs339/es/.
  • Orth SR, Hallan SI. Smoking: A Risk Factor for Progression of Chronic Kidney Disease and for Cardiovascular Morbidity and Mortality in Renal Patients—Absence of Evidence or Evidence of Absence? Clin J Am Soc Nephrol. 2008; 3(1):226-236.
  • Orth SR, Ritz E. The renal risks of smoking: an update. Curr Opin Nephrol Hypertens. 2002; 11(5):483-488.
  • Perazzi B, Angerosa M. Creatinina en sangre: calidad analítica e influencia en la estimación del Índice de Filtrado Glomerular. Acta Bioquímica Clínica Latinoam. 2011; 45(2):265-272.
  • Pickering JW, Endre ZH. The Metamorphosis of Acute Renal Failure to Acute Kidney Injury | IntechOpen [Internet]. intechopen.com. [citado 30 de junio de 2018; actualizado 2 de marzo de 2012]. Disponible en: https://www.intechopen.com/books/basic-nephrology-and-acute-kidney-injury.
  • Repetto Jiménez M. Toxicología Fundamental. 1.ª ed. España: Ediciones Díaz de Santos, S.A.; 2013.
  • Rocco MV, Soucie JM, Reboussin DM, McClellan WM. Risk factors for hospital utilization in chronic dialysis patients. J Am Soc Nephrol. 1996; 7(6):889-896.
  • Sanz Parras FJ. Biomarcadores de daño renal temprano asociados al consumo de tabaco. Universidad de Salamanca; 2016.
  • Sirota JC, Klawitter J, Edelstein CL. Biomarkers of Acute Kidney Injury. J Toxicol. 2011; 2011:1-10.
La source de données: Dialnet